東和薬品【JP:4553】損益計算書
時価総額
¥1864.9億
PER
10.1倍
医療用医薬品の製造販売を主軸に、ジェネリック医薬品の製造・販売、健康食品の企画・開発、受託製造を行う事業。
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| 売上高 | 48,719 | 55,241 | 61,351 | 71,470 | 82,115 | 84,949 | 93,430 | 105,104 | 110,384 | 154,900 | 165,615 | 208,859 | 227,934 | 259,594 |
| 売上原価 | - | - | - | 34,487 | 40,261 | 45,902 | 50,379 | 56,705 | 59,738 | 89,448 | 95,429 | 136,145 | 146,551 | 164,865 |
| 売上総利益 | - | - | - | 36,983 | 41,854 | 39,046 | 43,050 | 48,399 | 50,646 | 65,451 | 70,185 | 72,713 | 81,383 | 94,729 |
| 売上総利益率（％） | - | - | - | |||||||||||
| 営業利益 | - | - | - | 11,105 | 11,134 | 6,869 | 11,643 | 15,968 | 16,143 | 19,923 | 19,205 | 5,514 | 17,647 | 23,242 |
| 営業費用 | - | - | - | 25,877 | 30,719 | 32,176 | 31,407 | 32,431 | 34,503 | 45,527 | 50,980 | 67,199 | 63,735 | 71,486 |
| 経常（税引前）利益 | 9,841 | 9,544 | 8,834 | 15,437 | 10,157 | 7,417 | 11,717 | 18,865 | 20,990 | 18,677 | 22,739 | 5,141 | 24,477 | 26,152 |
| 法人税等合計 | - | - | - | 4,088 | 2,219 | 1,661 | 3,338 | 5,410 | 6,206 | 4,770 | 6,331 | 2,404 | 8,286 | 7,343 |
| 純利益 | 5,696 | 6,091 | 5,807 | 11,118 | 7,684 | 5,576 | 6,495 | 13,475 | 14,503 | 13,958 | 15,914 | 2,201 | 16,173 | 18,986 |
| 一株あたり利益 | 334.48 | 364.87 | 352.61 | 654.2 | 462.57 | 339.96 | 395.99 | 273.85 | 294.74 | 283.62 | 323.36 | 44.72 | 328.59 | 385.71 |
| 希薄化後一株あたり利益 | - | - | - | - | 436.29 | 314.23 | 366.08 | 253.32 | 272.62 | 271.93 | 316.19 | - | - | - |
| 配当性向（%） | - | - | - | - | - | - | - | - | - | - | - | |||
| 一株あたり配当金 | 75 | 75 | 75 | 95 | 95 | 95 | 95 | 107.5 | 44 | 44 | 60 | 60 | 60 | 70 |